SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018172
Filing Date
2024-05-08
Accepted
2024-05-08 08:55:48
Documents
17
Period of Report
2024-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 70335
2 ex4-1.htm EX-4.1 146382
3 ex10-1.htm EX-10.1 74344
4 ex99-1.htm EX-99.1 10916
  Complete submission text file 0001493152-24-018172.txt   583184

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tcbp-20240506.xsd EX-101.SCH 4054
6 XBRL DEFINITION FILE tcbp-20240506_def.xml EX-101.DEF 27117
7 XBRL LABEL FILE tcbp-20240506_lab.xml EX-101.LAB 37499
8 XBRL PRESENTATION FILE tcbp-20240506_pre.xml EX-101.PRE 25737
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6942
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41231 | Film No.: 24924440
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)